Exploring the Content Validity of Patient‐Reported Outcome Measures to Capture the Patient Experience of Becker Muscular Dystrophy
Muscle & Nerve · 2026-09 · 74 (3) · 559-569
DOI: 10.1002/mus.70302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 17.06.2026. Verfasst von Abby Bronson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Edgewise Therapeutics, Boulder, Colorado, USA. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Muscular Dystrophy, Duchenne, Quality of Life. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Edgewise Therapeutics, Boulder, Colorado, USA.
Abstract (Originalsprache)
Introduction/Aims The patient experience of Becker muscular dystrophy (BMD) is not well understood, making it difficult to evaluate the conceptual relevance of proposed patient‐reported outcome (PRO) measures. This study aimed to conceptualize the patient experience of BMD and evaluate content validity and perceptions of meaningful changes of PRO measures in this population.
Methods
Semi‐structured interviews were conducted with ambulatory adult and adolescent US‐based participants with BMD. Transcripts were analyzed using content and framework analysis. Participant quotes were coded to identify concepts and themes, illustrated in a conceptual model of BMD experience. Cognitive debriefing methods assessed patient understanding of the brief pain inventory‐short form (BPI‐SF), quality of life in neurological disorders (Neuro‐QoL), and three patient‐reported outcomes measurement information system (PROMIS‐57) domains: Physical Function, Fatigue, and Pain Interference.
Results
Twenty‐nine patients (mean age: 27.0 years; mean age at BMD diagnosis: 15.1 years) and two caregivers described a wide range of signs, symptoms, and impacts. Physical fatigue, pain, weakness, and impacts on physical mobility and emotional wellbeing were considered most bothersome. The BPI‐SF Item 3 and PROMIS‐57 domains were well understood and relevant; however, the Neuro‐QoL Upper Extremity questionnaire demonstrated low conceptual relevance.
Discussion
The conceptual model illustrated the burden of living with BMD. The BPI‐SF Item 3 and evaluated PROMIS‐57 domains are considered content‐valid PRO measures in BMD, with most participants associating score improvements with meaningful changes to their health‐related quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Edgewise Therapeutics, Boulder, Colorado, USA.
- Clinical Outcomes Assessment, Clarivate, London, UK.
- Foundation for Angelman Syndrome Therapeutics, Formerly Parent Project Muscular Dystrophy, Austin, Texas, USA.
ORCID-Profile: Katie Mellor, Natalie Aldhouse
Förderung
- Edgewise Therapeutics, Boulder, Colorado, USA
Zitieren
APA
Bronson, A., Mellor, K., Kilburn, N., Fischer, R., Aldhouse, N., Marshall, C., & Al-Zubeidi, T. (2026). Exploring the Content Validity of Patient‐Reported Outcome Measures to Capture the Patient Experience of Becker Muscular Dystrophy. Muscle & Nerve, 74(3), 559-569. https://doi.org/10.1002/mus.70302
Vancouver
Bronson A, Mellor K, Kilburn N, Fischer R, Aldhouse N, Marshall C, et al. Exploring the Content Validity of Patient‐Reported Outcome Measures to Capture the Patient Experience of Becker Muscular Dystrophy. Muscle & Nerve. 2026;74(3):559-569. doi:10.1002/mus.70302
BibTeX
@article{Bronson2026,
author = {Bronson, Abby and Mellor, Katie and Kilburn, Nicole and Fischer, Ryan and Aldhouse, Natalie and Marshall, Chris and Al-Zubeidi, Tamara},
title = {Exploring the Content Validity of Patient‐Reported Outcome Measures to Capture the Patient Experience of Becker Muscular Dystrophy},
journal = {Muscle & Nerve},
year = {2026},
volume = {74},
number = {3},
pages = {559--569},
doi = {10.1002/mus.70302}
}
EUVIMED